lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1

被引:1
|
作者
Gu, Jie [1 ]
Dai, Bo [1 ]
Shi, Xuchao [1 ]
He, Zhennian [1 ]
Xu, Yuanlin [1 ]
Meng, Xiangqian [2 ]
Zhu, Junlan [3 ]
机构
[1] Beilun Peoples Hosp, Dept Orthopaed Surg, Ningbo, Zhejiang, Peoples R China
[2] Beilun Peoples Hosp, Dept Stomatol, Ningbo, Zhejiang, Peoples R China
[3] Beilun Peoples Hosp, Precis Med Lab, Ningbo, Zhejiang, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 17期
关键词
osteosarcoma; long non-coding RNA; human leukocyte antigen complex group 11; p27; Kip1; miR-942-5p; IGF2BP2; TUMORIGENESIS; EXPRESSION;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Osteosarcoma (OS) is a common malignant bone cancer threatening children and young adults. Emerging evidence indicates that long non-coding RNAs (lncRNAs) play crucial roles in the progression of OS. Herein, we want to clarify the roles of lncRNA human leukocyte antigen complex group 11 (HCG11) in OS. Our data revealed that HCG11 expression is decreased in OS, which is a result of transcriptional repression of YY1. Low HCG11 level is closely associated with larger tumor size and shorter overall survival of OS patients. HCG11 negatively regulates cell proliferation, cell cycle, DNA replication in vitro and tumor growth in vivo. HCG11 can raise p27 Kip1 expression via binding to miR-942-5p and IGF2BP2, and p27 Kip1 acts as a key effector for HCG11 exerting biological functions. In conclusion, HCG11 is downregulated in OS, and restrains OS growth both in vitro and in vivo by raising p27 Kip1 expression via binding to miR-942-5p and IGF2BP2.
引用
收藏
页码:21743 / 21757
页数:15
相关论文
共 50 条
  • [21] Molecular analysis of the P27/Kip1 gene in breast cancer
    Tigli H.
    Buyru N.
    Dalay N.
    Molecular Diagnosis, 2005, 9 (1) : 17 - 21
  • [22] Aberrant p27(kip1) expression in endocrine and other tumors
    Lloyd, RV
    Jin, L
    Qian, X
    Kulig, E
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 150 (02): : 401 - 407
  • [23] Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium
    Tong, L.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (01) : 157 - 157
  • [24] Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression
    Fernández, PL
    Arce, Y
    Farré, X
    Martínez, A
    Nadal, A
    Rey, MJ
    Peiró, N
    Campo, E
    Cardesa, A
    JOURNAL OF PATHOLOGY, 1999, 187 (05): : 563 - 566
  • [25] Reduced levels of p27/kip1 protein in human prostate cancer: An immunohistochemical analysis
    Erdamar, S
    Yang, G
    Wheeler, TM
    Kattan, M
    Harper, JW
    Thompson, TC
    MODERN PATHOLOGY, 1998, 11 (01) : 81A - 81A
  • [26] Expression of p27( KIP1) and cyclin D1, and cell proliferation in human pterygium
    Kase, Satoru
    Takahashi, Shuji
    Sato, Izuru
    Nakanishi, Katsuya
    Yoshida, Kazuhiko
    Ohno, Shigeaki
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2007, 91 (07) : 958 - 961
  • [27] Translational control of p27(Kip1) accumulation during the cell cycle
    Hengst, L
    Reed, SI
    SCIENCE, 1996, 271 (5257) : 1861 - 1864
  • [28] A clinicopathologic study of p27(kip1) expression in renal allograft biopsy
    Oka, K.
    Namba, Y.
    Moriyama, T.
    Kyo, M.
    Tsukiyama, A.
    Tsujimoto, M.
    Kokado, Y.
    Imai, E.
    Takahara, S.
    TRANSPLANTATION PROCEEDINGS, 2007, 39 (10) : 3068 - 3071
  • [29] Expression of cell cycle inhibitor p27 Kip1 in nevi and melanomas
    Akman, Ayse
    Ciftcioglu, M. Akif
    Ozbey, Caner
    Alpsoy, Erkan
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2008, 74 (05):
  • [30] Clinical Impact of p27 Kip1 and CaSR Expression on Primary Hyperparathyroidism
    Aycicek, Gozde Sengul
    Aydogan, Berna Imge
    Sahin, Mustafa
    Ersoz, Cevriye Cansiz
    Sak, Serpil Dizbay
    Baskal, Nilgun
    ENDOCRINE PATHOLOGY, 2018, 29 (03) : 250 - 258